Abstract:Objective To investigate the effect of botulinum toxin type A in the patients with lower limb muscle spasm after cerebral hemorrhage. Methods One hundred and four patients with lower limb muscle spasm after cerebral hemorrhage admitted to our hospital from March 2014 to August 2015 were selected. According to the random number table method, the patients were divided into the observation group (botulinum toxin type A) and the control group (alcohol). The lower extremity function, walking speed, joint mobility and other related indicators were compared between the two groups. Results Before treatment, there was no significant difference in MAS, FMA or BBS score between the two groups (P > 0.05). After treatment, the MAS score of the observation group was significantly lower than that of the control group, while FMA and BBS scores were significantly higher than those of the control group (P < 0.05). Before treatment, there was no significant difference in walking speed, 10-meter walking time or 3-meter up-sitting time between the two groups (P > 0.05). After treatment, the 10-meter walking time and 3-meter up-sitting time of the observation group were significantly shorter than those of the control group, while the walking speed was faster than that of the control group (P < 0.05). Before treatment, there was no significant difference in muscle surface electromyographic score or passive range of motion between the two groups (P > 0.05). After treatment, the muscle surface electromyographic score of the observation group was significantly lower than that of the control group, the passive range of motion was significantly higher than the control group (P < 0.05). Conclusions Local injection of botulinum toxin type A has remarkable effect in the treatment of lower limb spasticity in the patients with cerebral hemorrhage. It can relieve muscle spasm of the lower limbs, significantly improve lower limb motor function, and increase joint mobility in the patients, and is worthy of promotion.